Epigenetically conferred ring-stage survival in Plasmodium falciparum against artemisinin treatment

Artemisinin and its semisynthetic derivatives (ART) are crucial medicines in artemisinin-based combination therapies worldwide. Despite ART's efficacy, small proportions of young intraerythrocytic ring stage parasites can survive the drug's short half-life, and dormant forms can cause recrudescence if not cleared by partner drugs. Certain mutations in the Kelch propeller region of P. falciparum protein (PfK13) are linked to the higher ring-stage survival (RS), which above 1% can be a feature of 'artemisinin partial resistance'. Emerging evidence indicates epigenetic modulators may contribute to RS. Here, we report systematic evaluations of all putative histone acetyltransferases (HATs) of P. falciparum in 30 culture-adapted field isolates and 43 subcloned field isolates. Only PfMYST shows a full association with RS phenotype modulations. Knockdown experiments confirm the linkage of Pfmyst expression to these modulations, with evidence of altered metabolic processes. Through single-cell RNA sequencing, ChIP-seq analysis, and CRISPR/cas9 genetic manipulation, PfMYST-targeted RS-related genes have been identified and functionally validated. Multi-omics analysis indicates significant interplay of PfMYST and PfK13 mechanisms in RS. PfMYST epigenetic modulation extends to other antimalarials, including amodiaquine, pyrimethamine, chloroquine, and pyronaridine. Collectively, our findings provide important information on the epigenetic regulatory mechanism of P. falciparum RS after pulses of ART and other antimalarials.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2025-08-28
DOI
https://doi.org/10.1038/s41467-025-62479-2
Citations
2
Primary Topic
Malaria Research and Control
Type
article
Field-Weighted Citation Impact
3.76

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Epigenetically conferred ring-stage survival in Plasmodium falciparum against artemisinin treatment

Juliana M. Sá, Cizhong Jiang, Qingfeng Zhang, Lucien Platon et al.
2 citations
Nature Communications
Malaria Research and Control
3.76
article

Epigenetically conferred ring-stage survival in Plasmodium falciparum against artemisinin treatment

Juliana M. Sá, Cizhong Jiang, Qingfeng Zhang, Lucien Platon, Xinyu Yu, Xuan Chen, Wenwen Si, Shiyin Liu, Jun Cao, Thomas E. Wellems, Ruoyu Tang, Jianbing Mu, Didier Ménard, Xiaohui He, Jincan He, Changhong Wang, Jianxia Tang, Yuemeng Zhao
article en
2 citations

Abstract

Artemisinin and its semisynthetic derivatives (ART) are crucial medicines in artemisinin-based combination therapies worldwide. Despite ART's efficacy, small proportions of young intraerythrocytic ring stage parasites can survive the drug's short half-life, and dormant forms can cause recrudescence if not cleared by partner drugs. Certain mutations in the Kelch propeller region of P. falciparum protein (PfK13) are linked to the higher ring-stage survival (RS), which above 1% can be a feature of 'artemisinin partial resistance'. Emerging evidence indicates epigenetic modulators may contribute to RS. Here, we report systematic evaluations of all putative histone acetyltransferases (HATs) of P. falciparum in 30 culture-adapted field isolates and 43 subcloned field isolates. Only PfMYST shows a full association with RS phenotype modulations. Knockdown experiments confirm the linkage of Pfmyst expression to these modulations, with evidence of altered metabolic processes. Through single-cell RNA sequencing, ChIP-seq analysis, and CRISPR/cas9 genetic manipulation, PfMYST-targeted RS-related genes have been identified and functionally validated. Multi-omics analysis indicates significant interplay of PfMYST and PfK13 mechanisms in RS. PfMYST epigenetic modulation extends to other antimalarials, including amodiaquine, pyrimethamine, chloroquine, and pyronaridine. Collectively, our findings provide important information on the epigenetic regulatory mechanism of P. falciparum RS after pulses of ART and other antimalarials.

Nature CommunicationsVol. 16(1)
Tongji University (CN), National Institutes of Health (US), Nanchang University (CN), Inserm (FR), Institut Pasteur (FR), Institut Universitaire de France (FR), Université Paris Cité (FR), Jiangsu Institute of Parasitic Diseases (CN), Shanghai East Hospital (CN), National Institute of Allergy and Infectious Diseases (US), Tongji Hospital (CN), Université de Strasbourg (FR), Nanjing Medical University (CN)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Alliance Française contre les Maladies Parasitaires, Agence Nationale de la Recherche, National Natural Science Foundation of China, Fondation pour la Recherche Médicale, Tongji University, Institut Universitaire de France, National Institutes of Health, National Institute of Allergy and Infectious Diseases, NHLBI Division of Intramural Research
Zero hunger
Openalex Percentile: Top 6%
Malaria Research and Control
3.76
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.